A technique called Mendelian randomization is overturning the conclusions of observational studies in public health. But researchers question whether the method can overcome its fundamental limitations.

Political newcomers to federal and state legislatures with STEM backgrounds are bringing evidence to drafting laws, yet getting bills passed remains elusive.

Health officials are rushing a genetically engineered product into the field to counter uncontained outbreaks of vaccine-derived polio.

The scholarly publisher has announced several new licensing agreements in both Europe and the US—but some major academic groups are still without contracts and access to journals.

While short-term disruptions are manageable, scientists say, they are still concerned the unrest—and possible political ramifications—will affect the country’s research programs long-term.

Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.

Plagiarism and bribery are commonplace, they say, and they’ve begun calling out lapses in scientific integrity.

Experimental surgeries to prevent seizures may help scientists understand the link between autism and epilepsy.

Companies are selling reports about a wide range of physical, cognitive, and behavioral traits to consumers based on their genomic data, but such tests have a number of limitations.